Image & Video

SASHA: AI that analyzes gigapixel pathology slides with 80-90% less data

A reinforcement learning model that zooms into diagnostic spots, not whole slides.

Deep Dive

Deep neural networks are transforming histopathology, but whole-slide images (WSIs) are gigapixel-scale, making it computationally prohibitive to analyze every region at high resolution. Diagnostic labels are often available only at the slide level, and the informative tissue regions can occupy as little as 10% of the slide.

To tackle this, Tarun Gogisetty, Naman Malpani, Gugan Thoppe, and Sridharan Devarajan propose SASHA (Sequential Attention-based Sampling for Histopathological Analysis), a deep reinforcement learning framework accepted at NeurIPS 2025. SASHA first trains a lightweight, hierarchical attention-based multiple instance learning (MIL) model to learn which patches are likely to contain diagnostic features. Then, instead of processing the entire WSI at full resolution, SASHA uses a reinforcement learning agent to sequentially sample and zoom into only the most informative high-resolution patches — covering just 10–20% of the slide.

Experiments show that SASHA matches or exceeds the accuracy of methods that analyze the entire WSI at full resolution, while using a fraction of the computational and memory resources. It also significantly outperforms competing sparse sampling approaches. The authors propose SASHA as an intelligent sampling model for any medical imaging task involving exceptionally large images with sparsely informative features. Code is available on GitHub, enabling integration into clinical workflows. This efficiency gain could make AI-powered pathology more scalable and affordable for real-world hospitals.

Key Points
  • SASHA uses deep reinforcement learning to decide which 10-20% of high-resolution patches to analyze, bypassing the need to scan the entire gigapixel WSI.
  • It matches state-of-the-art accuracy of full-resolution analysis while drastically reducing compute and memory costs.
  • Accepted at NeurIPS 2025; code is open-source to enable adoption in clinical pathology pipelines.

Why It Matters

Enables scalable, cost-effective AI diagnosis on massive medical images without sacrificing accuracy.

📬 Get the top 10 AI stories daily